Medicines and Related Substances Control Act, 1965 (Act No. 101 of 1965)

22G. Pricing committee

Purchase

(1)	The Minister shall appoint, for a period not exceeding five years, such persons as he or she may deem fit to be members of a committee to be known as the pricing committee.

[Section 22G(1) substituted by section 8(a) of Act No. 59 of 2002]

(2)	The Minister may, on the recommendation of the pricing committee, make regulations—

(a)	on the introduction of a transparent pricing system for all medicines and Scheduled substances sold in the Republic;

(b)	on an appropriate dispensing fee to be charged by a pharmacist or by a person licensed in terms of section 22C(1)(a).

(c)	on an appropriate fee to be charged by wholesalers or distributors or any other person selling Schedule 0 medicines.

[Section 22G(2)(c) inserted by section 8(b) of Act No. 59 of 2002]

(3)

(a)	The transparent pricing system contemplated in subsection (2)(a) shall include a single exit price which shall be published as prescribed, and such price shall be the only price at which manufacturers shall sell medicines and Scheduled substances to any person other than the State.

(b)	No pharmacist or person licensed in terms of section 22C(1)(a) or wholesaler or distributor shall sell a medicine at a price higher than the price contemplated in paragraph (a).

[Section 22G(3)(b) substituted by section 8(c) of Act No. 59 of 2002]

(c)	Paragraph (b) shall not be construed as preventing a pharmacist or person licensed in terms of this Act to charge a dispensing fee as contemplated in subsection (2)(b).

(4)	To the members of the pricing committee who are not in the full-time employment of the State may be paid such remuneration and allowances as the Minister, with the concurrence of the Minister of Finance, may determine.

[Section 22G inserted by section 14 of Act No. 90 of 1997]